Highlights Kyowa Corporation

Equities

Market Closed - Japan Exchange Other stock markets 11:25:00 04/07/2024 am IST			5-day change	1st Jan Change
872 ^JPY	-1.02%		-1.47%	+8.05%

05/06	Kyowa Kirin Repurchases 3.3 Million Shares in May	MT
07/05	Kyowa Kirin's Profit Up 15% in Q1	MT

Kyowa Kirin Repurchases 3.3 Million Shares in May	05/06	MT
Kyowa Kirin's Profit Up 15% in Q1	07/05	MT
Kyowa Kirin Buys Back Shares for 5.6 Billion Yen in April	06/05	MT
BridgeBio Pharma Shares Decline After Q1 Financial Results	02/05	MT
Kyowa Kirin Buys Back 4 Billion Yen Worth of Shares in March	03/04	MT
Japanese Shares Slip into Red Amid Profit-Taking; Tokyo Inflation Eyed	25/03	MT
Kyowa Kirin to Allocate Over 84,000 Treasury Shares as Director, Officer Compensation	25/03	MT
Kyowa Kirin's gene therapy most expensive US drug with $4.3 million price tag	20/03	RE
US approves first gene therapy for children with rare genetic disease	19/03	RE
Kyowa Kirin Buys Back Nearly 3 Billion Yen of Shares	05/03	MT
Japan's Nikkei closes at 34-year peak on dovish BOJ; tech shares soar	08/02	RE
Japan's Nikkei leaps to 2-week high on tech stocks, yen boost	08/02	RE
Kyowa Kirin's Profit Up 52% in Fiscal 2023	07/02	MT
Orchard Therapeutics Completes Sale to Japan's Kyowa Kirin	24/01	MT
Aosaikang Pharmaceutical Registers Breast Cancer Drug	23/01	MT
Kyowa Kirin’s Attributable Profit up 8.8% in Nine Months Ended Sept. 30 on Gain on Sales of Share and Valuation	02/11	MT
Orchard Therapeutics ADSs Soar Premarket on Takeover by Kyowa Kirin	05/23/05	DJ
Orchard Therapeutics to Be Acquired by Kyowa Kirin for at Least $16 per American Depositary Share in Cash	05/23/05	MT
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln	05/23/05	RE
Ardelyx Says Partner Received Approval for Tenapanor to Treat Hyperphosphatemia in Japan	25/23/25	MT

No results for this search